Figure 1. Fused SPECTICTscanshowsincreased uptakeof99mTc sestamibi in the left superior parathyroid(arrow).
A 67-year-old woman on chronic hemodialysis for end-stage renal disease presented to our clinic with abnormal laboratory values consistent with hyperparathyroidism. A 99mTc sestamibi scan performed at another hospital was suggestive of a possible parathyroid adenoma. A fused single photon-emission computed tomography (SPECT)/CT scan conducted at our institution showed increased radiotracer uptake by the left superior parathyroid gland (figure 1), consistent with a parathyroid adenoma. Despite the highly localized radiotracer uptake on SPECT/CT, the patient's history of chronic kidney disease with hemodialysis increased the likelihood of background secondary hyperparathyroidism, and therefore the patient was scheduled for a parathyroid exploration.
In the operating room, a midline approach was used to access the parathyroid glands. All four glands were identified, and the left superior gland was markedly enlarged (figure 2). Additionally, intraoperative pathology demonstrated hypercellularity of the other three glands. The patient's preoperative parathyroid hormone (PTH) level was 2,948 pg/ml; however, a re- Xoran MiniCAr " -the best inoffice, compact, upright volume computed tomography system designed for high-resolution bone window imaging of the sinuses, temporal bones and skull base.
The MiniCAT provides the perfect solution for increased patient and physician convenience, immediate access to images and a favorable return on investment. Our advanced technology offers ultra-low radiation dose protocols as well as quick scan and reconstruction times.
Xoran has had a 100% success rate for lAC accreditation applications for over SIX years, so rest assured that your application will be in good hands! With our NEW 2014 package offerings, the MiniCAT is now more affordable than everand includes an extended warranty with remote image backup and access.
Contact us today!
To find out more about our new attractive solutions, please call 1-800-709-6726 or email usat info@xorantech.com. peat PTH level drawn after the removal of the left superior gland was still >500 pg/ml, so the decision was made to proceed with a subtotal parathyroidectomy. One-halfof the right inferior parathyroid gland was tagged with nonabsorbable suture and left in place . with an intact vascular pedicle. The other half of the gland was minced and sent for cryopreservation. After the remaining two parathyroid glands were removed, the patient's PTH level dropped to 83.9 pg/ml and the surgical wound was closed.
Primary hyperparathyroidism occurs in 1 of 500 females and 1 of 2,000 males and may be sporadic, familial, or associated with multiple endocrine neoplasia (MEN) type I or type IIa. 1 Eighty to 90% of primary hyperparathyroidism cases result from parathyroid adenomas, which are usually spontaneous and in 90 to 98% of cases affect only one gland.I In contrast, secondary hyperparathyroidism results from parathyroid hyperplasia in response to hyperphosphatemia and vitamin D deficiency in patients with end-stage renal disease.I Irrespective of the cause, the high level of PTH observed with primary or secondary hyperparathyroidism increases osteoclast activity, which eventually leads to osteodystrophy. Accordingly, the goal of surgery in hyperparathyroidism is to normalize PTH levels. Because the half-life of PTH is 2 to 5 minutes, intraoperative PTH monitoring can be used to confirm the adequate removal of abnormal parathyroid tissue. Generally, PTH levels obtained after removal 160 • www.entjournal.com of the abnormal tissue that are normal or near-normal and >50% lower than the baseline PTH level are highly predictive of successful removal of all abnormal tissue.'
In the case of an isolated parathyroid adenoma and primary hyperparathyroidism, the abnormal gland can be removed through a minimally invasive approach.' Cases of suspected hyperplasia of all four glands or, rarely, double adenomas require parathyroid exploration with positive identification of all parathyroid glands. It is important to note that while most patients have four parathyroid glands, supranumerary glands may be present in up to 16.5% of the population.'
For surgical treatment of secondary hyperparathyroidism, a common approach is the removal of three and one-half glands (subtotal parathyroidectomy), leaving the remaining half gland in place with an intact vascular pedicle. Alternatively, a total parathyroidectomy may be performed, and one-half of one gland may be minced and reimplanted into shallow pockets created in the sternocleidomastoid or brachioradialis muscles. To allow for autologous reimplantation of parathyroid tissue should the patient's PTH levels drop too low, additional parathyroid tissue may be minced, placed in cryopreservation solution, and frozen for later use.' Intraoperative PTH monitoring may be used to confirm the removal of sufficient parathyroid tissue in most cases.
